Review one medical device using publicly available South Korea market, product, and reimbursement information. We record sources and retrieval dates, distinguish open questions for specialist review, and do not determine product classification, regulatory route, or eligibility. Any external specialist or follow-on GTM work is separately scoped.
We connect product-specific public evidence to a practical next step. Any formal specialist opinion, third-party work, or partner introduction is separately scoped and agreed before it proceeds.
Review publicly searchable MFDS product and company information and fields displayed in a public record only when an exact product can be identified. This is not a complete authorization dossier or a product-specific MFDS determination. Sources and retrieval dates are recorded.
Separate identified public information from assumptions and questions needing qualified specialist confirmation or customer and market validation. We do not determine product classification, regulatory route, or eligibility. Organize open issues into a proceed, pause, or validate-further decision.
When needed, we may help identify external providers and coordinate scope, quotes, timing, and outputs. External provider work is engaged separately, and providers give their own professional opinions.
Where a device and applicable reimbursement code can be identified, record the public reimbursement category, applicable criteria, and published ceiling amounts. Label non-covered listings and hospital-disclosed non-covered charges separately; neither is a negotiated supply price or verified hospital purchase price. Record sources and retrieval dates; leave unavailable figures unfilled.
Coordinate agreed workstreams, milestones, decisions, and next actions across the customer and any separately engaged specialists.
Map potential importer, distributor, or user-organization profiles as market-research leads—not verified partners or authorized importers. Current authorization, product status, and any business relationship require separate verification. Any introduction or meeting depends on product fit, availability, and mutual consent; none is guaranteed.
Illustrative review structure
A decision aid for one medical device—not a client case, regulatory opinion, authorization forecast, or promise of commercial results.
Record the device/model and intended use as supplied by the manufacturer; clarify scope before analysis.
List only identifiable public records or comparable products, each with a source and retrieval date; leave unsupported fields unfilled.
When an applicable code can be identified, report public reimbursement categories, criteria, and published ceiling amounts separately from non-covered listings and hospital-disclosed non-covered charges. These references are not negotiated supply prices or verified hospital purchase prices.
List potential importers, distributors, or user organizations as research leads—not verified partners or authorized importers. Current authorization, device status, and any business relationship require separate verification.
Distinguish sourced information from assumptions and questions that need specialist or market validation.
Organize the evidence around a proceed, pause, or validate-further choice, with limitations made explicit.
Identify candidate specialist workstreams and coordination needs; scope, provider, timing, fees, and outputs are agreed separately.
Illustrative structure — not a client engagement or product-specific regulatory opinion.
Discuss Your Device’s Korea EntryA defined workflow connects an initial public-information review to scoped next steps. Specialist work and introductions are agreed separately.
Define one medical device, its intended use at a high level, the target market question, and the decision the review should support.
Confirm research boundaries, data-use permissions, deliverables, timing, and fees in writing before work begins.
Review publicly searchable MFDS product and company information only when an exact record is identifiable, alongside relevant public market and reimbursement information. Record sources and retrieval dates, leave unavailable figures unfilled, and label unresolved questions. This is not a complete authorization dossier or a product-specific MFDS determination.
If external regulatory, legal, patent, quality, testing, translation, or other work is needed, the provider, relevant qualifications, scope, fees, timing, and responsibilities should be confirmed separately before engagement. External providers give their own professional opinions.
Support a proceed, pause, or validate-further decision and coordinate agreed next actions. Potential importers, distributors, or user organizations are research leads, not verified partners or authorized importers; current authorization, product status, and relationships require separate verification. Any contact depends on product fit, availability, and mutual consent.
Proposed Pricing
Reference prices are indicative, not binding offers. Each review is for one medical device. Scope, deliverables, timing, and final fees are confirmed in a written proposal before work begins.
Product-specific public-information market scan
Proposed price
Deeper market review with a GTM strategy summary
Proposed price
Proposed prices are not binding quotes. Formal regulatory, legal, intellectual-property, testing, translation, and other specialist work—and related third-party fees—are separately scoped and priced. Buyer or distributor introductions are not included unless separately agreed and require mutual consent. Public reimbursement listings, published ceiling amounts, and hospital-disclosed non-covered charges are references, not negotiated supply prices or verified hospital purchase prices.
Before committing to Korean regulatory work, travel, exhibitions, or local distribution, manufacturers can review product-specific public evidence, identify unresolved questions, and decide whether to proceed, pause, or validate further.
The review is intended to inform a business decision, not guarantee regulatory approval, reimbursement, a partner, sales, or market-entry success. Findings distinguish identified public information from assumptions and questions needing specialist confirmation or customer and market validation.
K-MedTech Gateway focuses on public-source market research and go-to-market project coordination for manufacturers evaluating South Korea.
External patent, legal, regulatory, quality, testing, translation, or specialist market work is separate. The relevant provider, qualifications, scope, fees, and responsibilities should be confirmed for that workstream before engagement; external providers give their own professional opinions.
How the product-specific review, proposed pricing, specialist coordination, and distributor-contact support are scoped.
Start with one device and a high-level decision question. Please do not send confidential technical files or patient information through the form.
Start a Product ReviewSubmit a high-level inquiry about one medical device and the decision question you are evaluating for Korea. Submission does not confirm acceptance, scope, timing, or an engagement. Any proposed work is scoped separately in writing.
